Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Semaglutide surgery risk? ultrasound study aims to keep patients safe

NCT ID NCT06420739

First seen Nov 20, 2025 · Last updated Jun 21, 2026 · Updated 33 times

Summary

This study looks at 100 fasting surgical patients who take semaglutide (a diabetes/weight-loss drug). Doctors will use a bedside ultrasound to check if their stomachs are truly empty before surgery, even after fasting. The goal is to find out how often a 'full stomach' happens and create safer anesthesia guidelines.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FASTING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Toronto Western Hospital

    Toronto, Ontario, M5T 2S8, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

semaglutide

What this could lead to

If successful, this could lead to better safety guidelines for surgical patients taking semaglutide, reducing the risk of complications during anesthesia.

What could go wrong

This is a small, observational study (100 people) that only looks at one hospital. It won't directly change treatment yet, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

Fasting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.